Fisher BioServices understands the critical elements on the path to commercialization of your cell therapy product. We partner with you in every stage of development; from early phase trials through phase III, licensure, and global commercial distribution. Our highly configurable cell therapy workflows are validated and provide standardization for both autologous and allogeneic processes.
A cell therapy clinical trial can fail for any number of reasons; many of which are unavoidable. However, some of these failures can be avoided by understanding the basic laws of nature and taking appropriate action to eliminate or minimize their effect. If you are manufacturing a cell-based therapy, then the protection of your products and the patients who receive them requires that you ensure temperature compliance. In the video below, I walk you through a discussion of the challenges presented when attempting to overcome some of the most fundamental physical laws in the pursuit of delivering cell based drug product from manufacturer to the patient.